Header Logo

Connection

DAVID ROWLEY to Heterografts

Back to Details
This is a "connection" page, showing publications DAVID ROWLEY has written about Heterografts.
DAVID ROWLEY
Connection Strength
0.034
Heterografts
  1. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG. Oncotarget. 2017 Jul 04; 8(27):44447-44464.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.